Physician

Samaneh Davoudimoghaddam, MD

According to 2025 Medicare claims, Samaneh Davoudimoghaddam, MD (NPI: 1073036612) practices ophthalmology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is RETINA INSTITUTE, PLLC (NPI: 1528303849; TIN: 461427591) and primary practice location at 98055-6238. Davoudimoghaddam is affiliated with the MultiCare Connected Care, LLC (ACO ID: A3631), participating under the MSSP model.

Davoudimoghaddam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 456 traditional Medicare patients, billed 16,000 HCPCS/CPT codes, and received $1,096,994 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 486 prescription claims across 152 beneficiaries totaling $11,334 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $233. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$548K$1.1M2023 Medicare payment: $249,161 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,096,994 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232383,088$249,161
202445616,000$1,096,994

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$17K$35K2018 Drug cost: $1,881 (USD; Tot_Drug_Cst)2020 Drug cost: $8,207 (USD; Tot_Drug_Cst)2021 Drug cost: $34,749 (USD; Tot_Drug_Cst)2022 Drug cost: $13,345 (USD; Tot_Drug_Cst)2023 Drug cost: $12,083 (USD; Tot_Drug_Cst)2024 Drug cost: $11,334 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181843$1,881
2019N/RN/RN/R
202046125$8,207
202171238$34,749
202260158$13,345
202375209$12,083
2024152486$11,334

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system152152$109
67028Injection of drug into eye146614$103
92014Established patient complete exam of visual system318611$99
92134Imaging of retina203663$32
92250Photography of the retina365644$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1924,150$6,054
OfloxacinOfloxacin1132,286$1,283
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat241,757$338
Ketorolac TromethamineKetorolac Tromethamine23623$318
LatanoprostLatanoprost401,405$236

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$233ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Samaneh Davoudimoghaddam, MD?

Tedicare shows public-source Medicare data for Samaneh Davoudimoghaddam, MD (NPI 1073036612), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samaneh Davoudimoghaddam, MD have ACO affiliation data?

Samaneh Davoudimoghaddam, MD is shown with ACO affiliation data for MultiCare Connected Care, LLC (MSSP, ACO ID A3631).

What billing organization is linked to Samaneh Davoudimoghaddam, MD?

Samaneh Davoudimoghaddam, MD is linked to RETINA INSTITUTE, PLLC (billing NPI 1528303849) in the available physician profile data.

Does Samaneh Davoudimoghaddam, MD have Open Payments data?

Samaneh Davoudimoghaddam, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.